Copeptin for risk stratification in acute illness: beyond cardiological problems
Copeptin (Cop) has been recently proposed as a reliable marker for the diagnosis of acute coronary syndrome, altough its concentration was found to increase in a variety of other severe clinical conditions. The aim of the present study was to assess the utility of Cop to identify high-risk patients...
Main Authors: | Roberto Cemin, Giuseppe Lippi, Luca Donazzan, Massimiliano Manfrin, Massimo Daves |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2013-10-01
|
Series: | Emergency Care Journal |
Subjects: | |
Online Access: | http://www.pagepressjournals.org/index.php/ecj/article/view/1183 |
Similar Items
-
The use of the biomarker “copeptin” for the diagnosis of acute chest pain in the Emergency Department
by: Elisa Conti, et al.
Published: (2011-09-01) -
Risk assessment of sepsis through measurement of proAVP (copeptin): a secondary analysis of the TRIAGE study
by: Milena Kloter, et al.
Published: (2021-09-01) -
SIGNIFICANCE OF COPEPTIN IN DIAGNOSTICS OF MYOCARDIAL INFARCTION
by: L. V. Kremneva
Published: (2017-12-01) -
Expression of copeptin and midkine in diabetic retinopathy and their significance
by: Jian-Dan Ren, et al.
Published: (2018-11-01) -
Copeptin in Patients with Pregnancy-Induced Hypertension
by: Agnieszka Marek, et al.
Published: (2021-06-01)